# Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules

> **NCT07507838** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Vigonvita Life Sciences** · enrollment: 24 (estimated)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** VV913 4mg group
- **DRUG:** VV913 8mg group
- **DRUG:** VV913 15mg group

## Key facts

- **NCT ID:** NCT07507838
- **Lead sponsor:** Vigonvita Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2026-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07507838

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07507838, "Safety and Pharmacokinetics Study of Multiple Ascending Doses of VV913 Capsules". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT07507838. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*